Skip to main content
NCBI home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2010 Apr 30;33(6):E55–E60. doi: 10.1002/clc.20667

The Relationship between CD40 Gene Polymorphism and Unstable Coronary Atherosclerotic Plaques

Cuiping Wang 1, Jinchuan Yan 1,✉, Ping Yang 1, Rongzeng Du 1, Guanghua Chen 1
PMCID: PMC6653033  PMID: 20552594

Abstract

Background

Recently, CD40 polymorphism was found to be associated with acute coronary syndromes. However, few study was involved in the relationship between CD40 polymorphism and the risk of the vulnerable plaque to rupture so far.

Materials and Methods

A total of 699 patients who have received coronary angiography were divided into 3 groups according to the morphological division of the plaques: complex lesions (343 cases), smooth lesions (131 cases), and control group (225 cases).The gene polymorphism was measured by the polymerase chain reaction and restriction fragment length polymorphism (PCR‐RFLP) and identified by sequencing.

Results

The CC genotype and C allele frequency of the CD40 gene in the complex lesions group is significantly higher than in the smooth lesions group and the control group (P < .001), while the TT genotype frequency in the complex lesions group is significantly lower than that of the smooth lesions group and the control group (P < .001). The C allele increased disruption risk of the plaques in the complex lesions group as compared with the smooth lesions group (odds ratio [OR]: 1.697, 95% confidence interval [CI]: 1.273–2.261). No significant differences in genotypes or allele frequencies were found between the smooth lesions group and the control group.

Conclusion

Our results suggested that CD40 (−1C/T) polymorphism was associated with unstable coronary atherosclerotic plaques. The C allele frequency increased the risk of disruption of the coronary atherosclerotic plaques. Copyright © 2010 Wiley Periodicals, Inc.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

References

  • 1. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006; 47: C7–C12. [DOI] [PubMed] [Google Scholar]
  • 2. Richardson PD. Biomechanics of plaque rupture: progress, problems, and new frontiers. Ann Biomed Eng 2002; 30(4): 524–536. [DOI] [PubMed] [Google Scholar]
  • 3. Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions—a structural analysis with histopathological correlation. Circulation 1993; 87: 179–187. [DOI] [PubMed] [Google Scholar]
  • 4. Finet G, Ohayon J, Rioufol G. Biomechanical interaction between cap thickness, lipid core composition and blood pressure in vulnerable coronary plaque: impact on stability or instability. Coron Artery Dis 2004; 15: 13–20. [DOI] [PubMed] [Google Scholar]
  • 5. Phipps RP. Atherosclerosis: the emerging role of inflammation and the CD40‐CD40 ligand system. Proc Natl Acad Sci USA 2000; 97: 6930–6932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Yan JC, Wu ZG, Kong XT, Zong RQ, Zhan LZ. Relation between upregulation of CD40‐CD40 ligand system and serum levels of matrix metalloproteinases and complex stenosis morphology in patients with acute coronary syndrome. Acta Pharmacol Sin 2004; 25(2): 251–256. [PubMed] [Google Scholar]
  • 7. Yan JC, Wu ZG, Li L, Zhong RQ, Kong XT. Clinical implication of increased expression of CD40L in patients with acute coronary syndrome. Chin Med J 2002; 115(4): 491–493. [PubMed] [Google Scholar]
  • 8. Yan JC, Zhu J, Gao L, Ma GS, Wu ZG, Kong XT. The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes. Clinica Chimica Acta 2004; 343(1–2): 155–159. [DOI] [PubMed] [Google Scholar]
  • 9. Aukrust P, Muller F, Ueland Thor BS, et al. Enhanced levels of soluble and membrane‐bound CD40 ligand in patients with unstable angina. Circulation 1999; 100(6): 614–620. [DOI] [PubMed] [Google Scholar]
  • 10. Jacobson EM, Concepcion E, Oasi T, Tomer Y. A Graves' disease‐associated Kozak sequence single‐nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 2005; 145: 2684–2691. [DOI] [PubMed] [Google Scholar]
  • 11. Li Y, Tian CX, Wang M, Xia ZE. Correlation of CD40 gene polymorphisms with acute coronary syndrome, hypertension, and diabetes. Natl Med J China 2007; 87(10): 690–694. [PubMed] [Google Scholar]
  • 12. Kaski JC, Chester MR, Chen L, Katritsis D. Rapid angiographic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis morphology. Circulation 1995; 92: 2058–2065. [DOI] [PubMed] [Google Scholar]
  • 13. Kim TY, Park YJ, Hwang JK, et al. A C/T polymorphism in the 5′‐untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid 2003; 13: 919–925. [DOI] [PubMed] [Google Scholar]
  • 14. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242–250. [DOI] [PubMed] [Google Scholar]
  • 15. Divies MJ. Stability and instability: two faces of coronary atherosclerosis. Circulation 1999; 100: 614–20. [DOI] [PubMed] [Google Scholar]
  • 16. Schroeder AP, Falk E. Vulnerable and dangerous coronary plaques. Atherosclerosis 1995; 118: S141–S149. [PubMed] [Google Scholar]
  • 17. Ojio S, Takatsu H, Tanaka T, et al. Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction. Circulation 2000; 102: 2063–2069. [DOI] [PubMed] [Google Scholar]
  • 18. Williams AE, Freeman MR, Chisholm RJ, Patt NL, Armstrong PW. Angiographic morphology in unstable angina pectoris. Am J Cardiol 1988; 62: 1024–1027. [DOI] [PubMed] [Google Scholar]
  • 19. Bugiardini R, Pozzati A, Borghi A, et al. Angiographic morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome. Am J Cardiol 1991; 67: 460–464. [DOI] [PubMed] [Google Scholar]
  • 20. Kroczek R, Hamelmann E. T‐cell costimulatory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodies. J Allergy Clin Immunol 2005; 116: 906–909. [DOI] [PubMed] [Google Scholar]
  • 21. Tomer Y, Concepcion E, Greenberg DA. A C/T single‐nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 2002; 12: 1129–1135. [DOI] [PubMed] [Google Scholar]
  • 22. Mukai T, Hiromatsu Y, Fukutani T, et al. A C/T polymorphism in the 5′ untranslated region of the CD40 gene is associated with later onset of Graves' disease in Japanese. Endocr J 2005; 52(4): 471–477. [DOI] [PubMed] [Google Scholar]
  • 23. Pineda B, Laporta P, Hermenegildo C, Cano A, García‐Pérez MA. A C/T polymorphism located at position‐1 of the Kozak sequence of CD40 gene is associated with low bone mass in Spanish postmenopausal women. Osteoporos Int 2008; 19(8): 1147–1152. [DOI] [PubMed] [Google Scholar]
  • 24. Skibola CF, Nieters A, Bracci PM, et al. A functional TNFRSF5 gene variant is associated with risk of lymphoma. Blood 2008; 111(8): 4348–4354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 1991; 115: 887–903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Kozak M. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem 1991; 266: 19867–19870. [PubMed] [Google Scholar]
  • 27. Jacobson EM, Huber AK, Akeno N, et al. A CD40 Kozak sequence polymorphism and susceptibility to antibody‐mediated autoimmune conditions: the role of CD40 tissue‐specific expression. Genes and Immunity 2007; 8: 205–214. [DOI] [PubMed] [Google Scholar]
  • 28. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high‐risk plaque: part I: evolving concepts. J Am Coll Cardiol 2005; 46: 937–954. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES